AN1.AU Anagenics Ltd

Consumer Defensive Personal Care Products Australian Securities Exchange
0.0050 AUD
Close of Oct 14, 2026
0.0050 0.0090
Market cap
AUD 4.93M
P/E
-
P/B
1.17x
ROE
7.3%
Dividend yield
-
Fundamental score
1.8/5

Ratios use the latest price and the fiscal year ending Jun 2026.

Is AN1.AU undervalued?

Graham number

The Graham number of Anagenics Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Anagenics Ltd fundamental analysis

9 of 22 checks passed

ROE 0/2

Low return on equity (7.3%), below 10%.

ROA 1/1

Return on assets (6.5%) is above the industry median (-30.2%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (115.8%) is above the industry median (-11.1%).

Revenue Growth 0/2

Revenue shrank 17.3% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (0.8%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 0/1

Operating cash flow does not cover 20% of total debt.

Interest Coverage 1/1

EBIT is 9.1x against interest expense, well covered.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 1/1

Price to book (1.2x) is below the industry median (6.8x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Anagenics Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Anagenics Ltd

Anagenics Limited engages in the health, wellness, and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pacific Islands. The company was formerly known as Cellmid Limited and changed it…

Full company profile